BBNX - Beta Bionics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.00
DETAILS
HIGH:
$25.00
LOW:
$14.00
MEDIAN:
$22.00
CONSENSUS:
$21.00
UPSIDE:
77.66%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 55.4% |
| EBIT Margin | -73.0% |
| EBITDA Margin | -73.0% |
| Operating Margin | -71.5% |
| Pretax Margin | -73.0% |
| Cont. Ops Margin | -73.0% |
| Net Margin | -73.0% |
| Bottom Line Margin | -73.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 8.66 |
| Quick Ratio | 7.96 |
| Solvency Ratio | -1.780 |
| Cash Ratio | 1.02 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-16.87
Peers avg: 25.4
|
| PEG Ratio | 0.21 |
| Forward PEG | 0.21 |
| Price/Book | 4.29 |
| Price/Sales | 12.32 |
| Price/FCF | -21.97 |
| Price/Op Cash Flow | -24.25 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0222 |
| Debt/Equity | 0.0254 |
| Debt/Capital | 0.0248 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.14 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.57 |
| Operating Cash Flow Ratio | -1.647 |
| Operating Cash Flow/Sales | -50.8% |
| Free Cash Flow/Operating Cash Flow | 110.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -6.97 |
| Capital Expenditure Coverage | -9.61 |
| Dividend + Capital Expenditure Coverage | -9.61 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.47 |
| EPS | -1.806 |
| Debt/Share | 0.1802 |
| Cash/Share | 5.41 |
| Book Value/Share | 7.10 |
| Tangible BV/Share | 7.10 |
| Equity/Share | 7.10 |
| Operating Cash Flow/Share | -1.257 |
| Capital Expenditure/Share | 0.131 |
| FCF/Share | -1.387 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.021 |
| Price/Fair Value | 4.29 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -16.54 |